Researchers have found a way to silence mitochondrial gene expression in living cells. The approach, which may involve the use of polymorpholino chimeras, could potentially be used to target mitochondrial diseases. The exact mechanisms and implications of this development are still being explored, with various studies investigating the roles of different factors in mitochondrial function and disease.